Hvidovre Hospital

Københavns Universitet

Santseharay Ramirez Almeida

Jens Bukh

Yiping Li

Judith Margarete Gottwein

Troels Kasper Høyer Scheel

Daryl Grant Humes

The present invention relates to nucleic acid sequences that encode hepatitis C viruses (HCV) that are useful in the fundamental research of HCV as well as in the search of a vaccine against HCV. In particular the present invention relates to nucleic acid sequences that comprises HCVs which are capable of expressing said virus when transfected into cells and are capable of infectivity in vivo.

Optimized HCV full-length infectious cell culture systems and applications thereof

The present invention relates to hepatitis C virus (HCV) culture systems of genotypes 1a, 3a, 4a, 5a, and 6a that directly contribute to HCV drug and vaccine development, to HCV basic research and better-individualized treatment of HCV infected patients.

HCV culture systems and direct-acting antiviral sensitivity

The present invention relates to nucleic acid sequences that encode hepatitis C viruses (HCV) of genotype 2b that are useful in the fundamental research of HCV as well as in the search of a vaccine against HCV. In particular the present invention relates to nucleic acid sequences that comprises HCVs, which are capable of expressing said virus when transfected into cells and are capable of infectivity in vivo.

High-titer HCV full-length genotype 2B infectious cell culture systems and applications thereof

HCV full-length infectious cell culture systems and applications thereof

Growing community of inventors

Hvidovre, Denmark

Santseharay Ramirez Almeida